Want to join the conversation?
$ENDP expects full-year 2015 total revenue to be between $3.22-3.27Bil, reported GAAP loss per share from continuing operations to be in the range of $3.70-3.60 and adjusted diluted EPS from continuing operations to be in the range of $4.50-4.60.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)